Boston Tech Watch: Polaris, GE, DataRobot, Facial Recognition Woes | Brian Dowling | 06/21/19 | Boston |
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More | Alex Lash | 06/07/19 | National |
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More | Alex Lash | 05/24/19 | National |
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More | Alex Lash | 01/11/19 | National |
FAANG, Public Trust, Valuations, in 2019: The Read from Menlo Ventures | Bernadette Tansey | 01/10/19 | San Francisco |
Tech Leaders Weigh In on Tim Berners-Lee’s “Contract for the Web” | Bernadette Tansey | 01/07/19 | National |
Coinbase, Circle & Others Form Blockchain Lobbying Group in DC | Jeff Bauter Engel | 09/12/18 | Boston |
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More | Alex Lash | 08/31/18 | National |
Bio Roundup: Alnylam’s Moment, Read on Rebates, Skinny Plans & More | Alex Lash | 08/03/18 | National |
EU Regulators Approve Akcea’s Inotersen. FDA Decisions Are Next. | Alex Lash | 07/11/18 | Boston |
Facebook: Lip Service to Privacy Is Over | Robert R. Ackerman | 04/18/18 | San Francisco |
Citing Losses, Fare Quits Austin as Uber, Lyft Resume Service | Angela Shah | 06/06/17 | Texas |
Tech in the Trump Era: Regulating Privacy, Immigration, Ethics | David Holley | 03/16/17 | Texas |
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More | Alex Lash | 03/03/17 | National |
Ex-FDA Commish Califf Gives Props to Patient Groups—With Caveats | Alex Lash | 01/23/17 | National |
Analysis: With a Tight Smile, Trump Details Economic Plan in Detroit | Sarah Schmid Stevenson | 08/08/16 | Detroit Ann Arbor |
Massachusetts Passes Uber Bill; Noncompete & Airbnb Proposals Fail | Jeff Bauter Engel | 08/01/16 | Boston |
Boston Tech Watch: HourlyNerd, Uber, Noncompetes, Akamai, & More | Jeff Bauter Engel | 07/05/16 | Boston |
FDA Commish Califf to Big Data Crowd: Flood Of New Treatments Coming | Alex Lash | 05/26/16 | National |
Boston Ride-Hailing Service Fasten Seeks Inroads to Austin Market | Angela Shah | 05/16/16 | Texas |
As Rivals Make News, Intercept Heads To Daylong Hearing For Liver Drug | Alex Lash | 04/06/16 | New York |
Spurned in Duchenne, BioMarin Will Seek Approval For Batten Drug | Alex Lash | 03/03/16 | San Francisco |
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund | David Holley | 07/29/15 | San Francisco |
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past | David Holley | 07/15/15 | Boston |
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials | David Holley | 07/10/15 | Boston |
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup | David Holley | 07/10/15 | Boston |
Bitcoin Startup Circle Grabs $50M to Add U.S. Dollar to Payment System | David Holley | 04/30/15 | Boston |
As Uber Becomes a Publisher, Boston Taxi Trade Paper Stops Printing | Curt Woodward | 03/05/15 | Boston |
Bridj’s Data-Driven Private Bus Fleet Heading to DC | Curt Woodward | 02/25/15 | Boston |
With New State Rules, WeFunder to Offer Equity Crowdfunding in MA | Curt Woodward | 01/16/15 | Boston |